Cardiac arrhythmias. 6. Present status of electroversion in the management of cardiac dysrhythmias.
D000925:Anticoagulants / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000628:therapy*; D001282:Atrial Flutter / Q000628:therapy; D006332:Cardiomegaly / Q000209:etiology; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004554:Electric Countershock / Q000009:adverse effects; D004562:Electrocardiography; D005500:Follow-Up Studies; D006801:Humans; D007022:Hypotension / Q000209:etiology; D008012:Lidocaine / Q000627:therapeutic use; D008722:Methods; D009203:Myocardial Infarction / Q000209:etiology; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011654:Pulmonary Edema / Q000209:etiology; D011655:Pulmonary Embolism / Q000209:etiology; D011802:Quinidine / Q000627:therapeutic use; D013610:Tachycardia / Q000628:therapy; D013614:Tachycardia, Paroxysmal / Q000628:therapy; D014693:Ventricular Fibrillation / Q000628:therapy
D000925:Anticoagulants; D004071:Digitalis Glycosides; D010672:Phenytoin; D008012:Lidocaine; D011802:Quinidine; D011342:Procainamide